As CMV infection is associated with increased expression of CD57 and down-regulation of NKG2A (52), most notably among FcRγneg (37) and NKG2Chigh (50) NK cells, the expression of these receptors was examined on the NK-cell subsets in vaccine trial participants (Figure 6B). The gene discussed is B3GAT1; the disease is cytomegalovirus infection.